John E. Milad work email
- Valid
- Valid
- Valid
- Valid
John E. Milad personal email
- Valid
John E. Milad phone numbers
As the CEO of ERS Genomics, I lead the global licensing of Nobel Prize-winning CRISPR/Cas9 gene-editing technology. Previously, as co-founder and CEO of Quanta Dialysis Technologies, I drove the development and commercial launch of an award-winning portable hemodialysis system in the US and UK, raising a record-breaking $245M funding round.My operational expertise is complemented by over a decade in healthcare venture capital, with notable exited investments including Symetis, ACT/EPIX, BoneSupport, and MedCast/WebMD. Recognized as one of UK’s 'Top 100 Game Changing Innovators and Entrepreneurs’ by the Sunday Times Maserati List, and a recipient of the MacRobert Award for outstanding engineering innovation.
-
Chief Executive OfficerErs GenomicsUnited Kingdom
-
Non Executive DirectorNorthern Venture Trust Plc Aug 2024 - Present -
Chief Executive OfficerErs Genomics May 2024 - PresentSan Francisco, Ca, UsGlobal leader in licensing CRISPR/Cas9 IP, a revolutionary gene-editing technology enabling the 21st century Bio Revolution.
-
Board TrusteeKidney Research Uk Nov 2023 - PresentPeterborough, Cambridgeshire, Gb -
Board MemberOtivio As Oct 2022 - Aug 2024Oslo, Oslo, No -
Board MemberInvizius Apr 2023 - Nov 2023Motherwell, North Lanarkshire, Gb -
Partner & Co-Head Of Healthcare VenturesDowning Llp Jan 2023 - Nov 20233 Lower Thames Street, London, Gb -
Chief Executive OfficerQuanta Dialysis Technologies Jan 2014 - Jul 2022Warwick, GbCEO and co-founder of venture-backed startup that developed an award-winning portable hemodialysis system to transform the delivery of kidney care. Led the company through critical milestones from early stage development to product launch in the UK and the US. Secured CE Mark and FDA clearance, established initial customers and commercial operations, and orchestrated a record-breaking $245 million private funding round. -
Founding Board MemberQuanta Dialysis Technologies 2009 - Jul 2022Warwick, Gb
-
Board MemberCellnovo Group 2011 - Dec 2013Paris, Fr -
Board MemberAdvanced Cardiac Therapeutics 2010 - Dec 2013Company subsequently renamed to Epix Therapeutics. -
Board MemberSymetis 2010 - Dec 2013Ecublens, Vaud, Ch -
Board ObserverBonesupport Ab Jun 2009 - Dec 2013Lund, Se -
Investment DirectorNbgi Ventures Mar 2009 - Dec 2013London, GbManaged a London-based venture capital fund backing innovative medtech startups across Europe and the US. Investments and portfolio companies included Quanta Dialysis Technologies, Symetis, Cellnovo, ACT (Epix) and BoneSupport. -
PresidentInsight Capital & Advisory 2005 - 2008Advisor to startup companies and investors in the life sciences sector.
-
Cfo, Head Of Finance And Business DevelopmentNitec Pharma Ag 2006 - 2007Executive at a specialty pharma start-up backed by Atlas Venture and ultimately acquired by Horizon Therapeutics. Led successful Series B fundraising. -
Special AdvisorAtlas Venture 2006 - 2007Cambridge, Ma, UsMember of London life sciences investment team. -
Associate Director, Healthcare Investment BankingNomura 2000 - 2005Tokyo, JpOfficer of investment banking team covering UK/European small cap and mid-market healthcare industry. -
AssociateKirkland Investors Llc 1997 - 2000Investment professional at a multi-family office making private equity and venture investments. -
Investment Banking AnalystLehman Brothers Inc. 1994 - 1997Us
John E. Milad Skills
John E. Milad Education Details
-
University Of ChicagoPolitical Science
Frequently Asked Questions about John E. Milad
What company does John E. Milad work for?
John E. Milad works for Ers Genomics
What is John E. Milad's role at the current company?
John E. Milad's current role is Chief Executive Officer.
What is John E. Milad's email address?
John E. Milad's email address is jo****@****ail.com
What is John E. Milad's direct phone number?
John E. Milad's direct phone number is +4479205*****
What schools did John E. Milad attend?
John E. Milad attended University Of Chicago.
What are some of John E. Milad's interests?
John E. Milad has interest in Health Care, Life Sciences, Digital Health, Medical Devices, Mhealth.
What skills is John E. Milad known for?
John E. Milad has skills like Venture Capital, Start Ups, Mergers And Acquisitions, Private Equity, Strategy, Due Diligence, Medical Devices, Entrepreneurship, Business Development, Biotechnology, Business Strategy, Executive Management.
Who are John E. Milad's colleagues?
John E. Milad's colleagues are Jon K., Paul Carter, Janice Valentine.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial